Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Other Pulmonary Disorders

Other Pulmonary Disorders

Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Pulmonary Tuberculosis II

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...

Pulmonary Tuberculosis III

Pulmonary Tuberculosis III

Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:

Skin Diseases and Disorders

Skin Diseases and Disorders

Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The repertoire of yeast species from human clinical samples in the United Kingdom 2016-2022: epidemiology, clinical relevance, and fluconazole resistance.

Microbiology spectrum·2026

Same author

From reporting gaps to hospital cost drivers to enhance digital health decision making: A machine learning-assisted analysis of national hospital data.

Digital health·2026

Same author

Reply to Chen et al., "Methodological considerations for the establishment of epidemiological cutoff values for <i>Sporothrix</i> species using CLSI broth microdilution".

Antimicrobial agents and chemotherapy·2026

Same author

Returning to Work After Maternity Leave: A Qualitative Study of Nurses' Experiences and Factors Influencing Their Retention.

Nursing open·2026

Same author

AI in the NICU: Considerations for Nursing Practice and Advocacy in Quality Care Outcomes for Patients and Families.

Advances in neonatal care : official journal of the National Association of Neonatal Nurses·2026

Same author

A cranberry extract stimulates procollagen I release and expression after UV radiation in a 3D skin model.

International journal of cosmetic science·2026

Search research articles

Related Experiment Video

Updated: Jul 2, 2025

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Pulmonary endemic mycoses.

Michael J Wilson¹, Irasha Harding², Andrew M Borman³

¹SpR in infectious diseases and microbiology, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.

Clinical Medicine (London, England)

|February 21, 2024

Summary

This summary is machine-generated.

Pulmonary endemic mycoses (PEM) are rare but increasing in the UK. Early clinical suspicion and travel history are crucial for timely diagnosis and treatment of these challenging respiratory infections.

Keywords:

Endemic mycoses Fungi Immunocompromised Infection Pulmonary

More Related Videos

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Related Experiment Videos

Last Updated: Jul 2, 2025

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Efficient Method for Imaging Murine Lungs that Preserves Spatial Dynamics of Fungal Spores in the Airways

Published on: December 13, 2024

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis

Published on: March 9, 2018

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Long Term Chronic Pseudomonas aeruginosa Airway Infection in Mice

Published on: March 17, 2014

Area of Science:

Medical Mycology
Infectious Diseases
Respiratory Medicine

Background:

Pulmonary endemic mycoses (PEM) are increasingly encountered in the UK.
Diagnosis of PEM can be challenging, causing treatment delays.

Purpose of the Study:

To summarize the epidemiology of PEM.
To outline key clinical features, diagnostic strategies, and management of PEM.

Main Methods:

Review of current literature on PEM epidemiology, clinical presentation, diagnosis, and management.
Emphasis on clinical suspicion in respiratory disease, especially in immunocompromised individuals or those unresponsive to empiric therapy.
Importance of obtaining extended travel history.

Main Results:

Increasing incidence of PEM in the UK.
Diagnostic challenges leading to delayed treatment.
Clinical suspicion and travel history are vital for prompt diagnosis.

Conclusions:

Raising clinical awareness of PEM is essential for early diagnosis.
Prompt diagnosis and appropriate management are critical for improving patient outcomes.
Further research may be needed to improve diagnostic and therapeutic strategies for PEM.